Keyphrases
Electronic Medical Records
100%
Advanced Solid Tumors
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Cisplatin
100%
Dose-escalation Study
100%
Status Report
100%
Ongoing Clinical Trials
100%
Cabazitaxel
100%
Patient-centered Care
100%
Maximum Tolerated Dose
100%
Resident Perceptions
66%
Venipuncture
66%
Survey Data
66%
United States
50%
Taxanes
42%
Faculty Education
33%
Frequency Perception
33%
Daily Frequency
33%
Length of Stay
33%
First Year
33%
Faculty Perceptions
33%
Patient Selection
33%
Internal Medicine Residency Program
33%
Hospitalized Patients
33%
Laboratory Testing
33%
Monthly Average
33%
Lung Cancer
33%
Sustained Change
33%
Medical Faculty
33%
Education Medical
33%
Metabolic Panel
33%
Complete Blood Count
33%
Order Information
33%
Clinical Cancer Research
33%
Ordering Practices
33%
Ordering Behavior
33%
Antitumor Activity
28%
Febrile Neutropenia
28%
Pharmacokinetics
28%
Acute Renal Failure
28%
Dose-limiting Toxicity
28%
Major Change
16%
Pediatric Research
16%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
16%
Biomarker Analysis
16%
Drop-down
16%
Targeted Therapy
16%
Open Study
16%
Advanced Search
16%
Biomarker Testing
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cabazitaxel
100%
Non Small Cell Lung Cancer
100%
Cisplatin
100%
Solid Malignant Neoplasm
100%
Maximum Tolerated Dose
100%
Clinical Trial
100%
Neoplasm
59%
Clinical Research
50%
Biological Marker
50%
Taxane
42%
Pharmacokinetics
42%
Lung Cancer
33%
Acute Kidney Failure
28%
Antitumor Activity
28%
Febrile Neutropenia
28%
Disease
28%
Epidermal Growth Factor Receptor Kinase Inhibitor
16%
Synergism
14%
Adverse Event
14%
Nausea
14%
Neutropenia
14%
Erethism
14%
Decreased Appetite
14%